Last quarter (Q4 2023), Ultragenyx Pharmaceutical's total revenue was $127.39M, an increase of 23.27% from the same quarter last year. In Q4, Ultragenyx Pharmaceutical's net income was $-123.19M. See Ultragenyx Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 372.27M	$ 434.25M	$ 363.33M	$ 351.41M	$ 271.03M	$ 103.71M
Cost of Revenue	-	-	-	-	$ 6.13M	$ 9.01M
Gross Profit	$ 434.25M	$ 434.25M	$ 363.33M	$ 351.41M	$ 264.90M	$ 94.71M
Operating Expense	$ 953.19M	$ 913.04M	$ 955.61M	$ 762.57M	$ 595.02M	$ 518.88M
Operating Income	$ -565.02M	$ -569.21M	$ -648.92M	$ -411.16M	$ -330.12M	$ -424.17M
Net Non Operating Interest Income Expense	$ 26.69M	$ 26.69M	$ 11.07M	$ 1.93M	$ -26.25M	$ 12.10M
Other Income Expense	$ -60.00K	$ -60.00K	$ 20.86M	$ 43.75M	$ 171.01M	$ 12.63M
Pretax Income	$ -608.46M	$ -608.46M	$ -701.73M	$ -452.98M	$ -185.36M	$ -399.44M
Tax Provision	$ -1.82M	$ -1.82M	$ 5.70M	$ 1.04M	$ 1.21M	$ 3.28M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -567.00M	$ -606.64M	$ -607.77M	$ -454.02M	$ -186.57M	$ -402.73M
Basic EPS	$ -8.33	$ -8.25	$ -10.12	$ -6.70	$ -3.07	$ -7.12
Diluted EPS	$ -8.33	$ -8.25	$ -10.12	$ -6.70	$ -3.07	$ -7.12
Basic Average Shares	$ 294.18M	$ 73.54M	$ 69.91M	$ 67.80M	$ 60.85M	$ 56.58M
Diluted Average Shares	$ 294.18M	$ 73.54M	$ 69.91M	$ 67.80M	$ 60.85M	$ 56.58M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 502.51M	$ 913.04M	$ 955.61M	$ 762.57M	$ 601.15M	$ 527.89M
Net Income From Continuing And Discontinued Operation	$ -606.64M	$ -606.64M	$ -707.42M	$ -454.02M	$ -186.57M	$ -402.73M
Normalized Income	$ -125.61M	-	$ -554.36M	-	$ -310.96M	$ -412.52M
Interest Expense	-	-	-	-	$ 33.29M	$ 1.14M
EBIT	$ -481.57M	$ -608.46M	$ -701.69M	$ 0.00	$ -152.07M	$ -398.31M
EBITDA	$ -318.19M	$ -595.30M	$ -680.77M	$ 0.00	$ -139.81M	$ -389.77M

Currency in USD

Ultragenyx Pharmaceutical Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing